# ![@BentheFidler Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1330055544.png) @BentheFidler Ben Fidler

Ben Fidler posts on X about $lly, $pfe, $bmy, $nvo the most. They currently have [-----] followers and [---] posts still getting attention that total [-----] engagements in the last [--] hours.

### Engagements: [-----] [#](/creator/twitter::1330055544/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1330055544/c:line/m:interactions.svg)

- [--] Week [-----] -23%
- [--] Month [------] +29%
- [--] Months [-------] +37%
- [--] Year [-------] -17%

### Mentions: [--] [#](/creator/twitter::1330055544/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1330055544/c:line/m:posts_active.svg)

- [--] Month [--] -49%
- [--] Months [---] +7.90%
- [--] Year [---] -14%

### Followers: [-----] [#](/creator/twitter::1330055544/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1330055544/c:line/m:followers.svg)

- [--] Week [-----] -0.02%
- [--] Month [-----] +0.24%
- [--] Months [-----] +1.40%
- [--] Year [-----] +2.80%

### CreatorRank: [-------] [#](/creator/twitter::1330055544/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1330055544/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  84.11% [finance](/list/finance)  11.26% [cryptocurrencies](/list/cryptocurrencies)  8.61% [currencies](/list/currencies)  7.28% [countries](/list/countries)  3.31% [technology brands](/list/technology-brands)  1.99% [vc firms](/list/vc-firms)  1.32% [us election](/list/us-election)  0.66%

**Social topic influence**
[$lly](/topic/$lly) #147, [$pfe](/topic/$pfe) 13.25%, [$bmy](/topic/$bmy) #48, [$nvo](/topic/$nvo) #103, [$mrk](/topic/$mrk) 7.28%, [$azn](/topic/$azn) #98, [$amgn](/topic/$amgn) 6.62%, [$bmrn](/topic/$bmrn) #10, [$jnj](/topic/$jnj) 5.96%, [$nvs](/topic/$nvs) 5.3%

**Top accounts mentioned or mentioned by**
[@byjongardner](/creator/undefined) [@gwendolynawu](/creator/undefined) [@lilahalvarado](/creator/undefined) [@realjacobbell](/creator/undefined) [@alexlash](/creator/undefined) [@nedpagliarulo](/creator/undefined) [@biopharmadive](/creator/undefined) [@scottgottliebmd](/creator/undefined) [@postopinions](/creator/undefined) [@iambicai](/creator/undefined) [@rebeccampifer](/creator/undefined) [@neavc](/creator/undefined) [@alnylam](/creator/undefined) [@atlasventure](/creator/undefined) [@luxcapital](/creator/undefined) [@editasmed](/creator/undefined) [@archimedes20311](/creator/undefined)

**Top assets mentioned**
[Eli Lilly and Company (LLY)](/topic/$lly) [Pfizer, Inc. (PFE)](/topic/$pfe) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Novo-Nordisk (NVO)](/topic/$nvo) [Merck & Co., Inc. (MRK)](/topic/$mrk) [AstraZeneca PLC (AZN)](/topic/$azn) [Amgen, Inc. (AMGN)](/topic/$amgn) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [Johnson & Johnson (JNJ)](/topic/$jnj) [Novartis AG (NVS)](/topic/$nvs) [Synthetify (SNY)](/topic/$sny) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) [AbbVie Inc (ABBV)](/topic/$abbv) [GSK plc (GSK)](/topic/$gsk) [Sanofi (SNY)](/topic/sanofi) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Insmed, Inc. (INSM)](/topic/$insm) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Moderna Inc (MRNA)](/topic/$mrna) [Hims & Hers Health, Inc. (HIMS)](/topic/$hims) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Vertex Protocol (VRTX)](/topic/$vrtx) [Arvinas, Inc (ARVN)](/topic/$arvn) [Incyte Corporation (INCY)](/topic/$incy) [Agios Pharmaceuticals, Inc. (AGIO)](/topic/$agio) [Metsera, Inc. (MTSR)](/topic/$mtsr) [Evommune, Inc. (EVMN)](/topic/$evmn) [Roivant Sciences Ltd. Common Shares (ROIV)](/topic/$roiv) [Biogen Inc (BIIB)](/topic/$biib) [Alkermes Inc. plc (ALKS)](/topic/$alks) [Amicus Therapeutics, Inc (FOLD)](/topic/$fold) [Sage Therapeutics, Inc (SAGE)](/topic/$sage) [PTC Therapeutics, Inc. (PTCT)](/topic/$ptct) [HilleVax, Inc. (HLVX)](/topic/$hlvx) [Vulcan Forged LAVA (LAVA)](/topic/$lava) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Instil Bio, Inc. (TIL)](/topic/$til) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Lexeo Therapeutics, Inc (LXEO)](/topic/$lxeo) [Janux Therapeutics, Inc. (JANX)](/topic/$janx) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [LENZ Therapeutics Inc (LENZ)](/topic/$lenz) [Summit Therapeutics Inc. Common Stock (SMMT)](/topic/$smmt) [Arcellx, Inc. (ACLX)](/topic/$aclx) [Terns Pharmaceuticals, Inc. (TERN)](/topic/$tern) [Corcept Therapeutics Inc. (CORT)](/topic/$cort) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Halozyme Therapeutics, Inc. (HALO)](/topic/$halo) [Wave Life Sciences Ltd. Ordinary Shares (WVE)](/topic/$wve) [BEAM (BEAM)](/topic/$beam)
### Top Social Posts
Top posts by engagements in the last [--] hours

"Amgen gives up on its once-prized eczema drug @ByJonGardner $AMGN $SNY https://www.biopharmadive.com/news/amgen-return-rocatinlimab-kyowa-kirin-atopic-dermatitis-eczma-ox40/810964/ https://www.biopharmadive.com/news/amgen-return-rocatinlimab-kyowa-kirin-atopic-dermatitis-eczma-ox40/810964/"  
[X Link](https://x.com/BentheFidler/status/2017284971501625718)  2026-01-30T17:13Z [----] followers, [---] engagements


"Sanofi drug inherited from Genzyme goes 1-for-2 in rare disease trials by @Lilah_Alvarado $SNY https://www.biopharmadive.com/news/sanofi-venglustat-gaucher-fabry-study-results/811113/ https://www.biopharmadive.com/news/sanofi-venglustat-gaucher-fabry-study-results/811113/"  
[X Link](https://x.com/BentheFidler/status/2018375606027637193)  2026-02-02T17:26Z [----] followers, [---] engagements


"Xoma strikes deals to buy struggling biotechs HilleVax Lava by @gwendolynawu #biotech $XOMA $HLVX $LAVA https://www.biopharmadive.com/news/xoma-hillevax-lava-therapeutics-zombie-biotechs/756678/ https://www.biopharmadive.com/news/xoma-hillevax-lava-therapeutics-zombie-biotechs/756678/"  
[X Link](https://x.com/BentheFidler/status/1952405607023088098)  2025-08-04T16:25Z [----] followers, [----] engagements


"Arrowhead showcases early obesity data; Instil bails on PD-1/VEGF drug $ARWR $TIL $JNJ $LLY $AMGN https://www.biopharmadive.com/news/arrowhead-obesity-instil-amgen-nimbus-disco-nipocalimab-lupus/808873/ https://www.biopharmadive.com/news/arrowhead-obesity-instil-amgen-nimbus-disco-nipocalimab-lupus/808873/"  
[X Link](https://x.com/BentheFidler/status/2008929266541486388)  2026-01-07T15:50Z [----] followers, [---] engagements


"Insmeds ginormous lung drug sales; J&Js US pricing deal $INSM $MLTX $LLY $LXEO $JNJ https://www.biopharmadive.com/news/johnson-price-insmed-moonlake-madrigal-pfizer-lexeo-lilly/809169/ https://www.biopharmadive.com/news/johnson-price-insmed-moonlake-madrigal-pfizer-lexeo-lilly/809169/"  
[X Link](https://x.com/BentheFidler/status/2009666283999056228)  2026-01-09T16:39Z [----] followers, [---] engagements


"Bristol Myers buys into Januxs masked T cell engagers by @Lilah_Alvarado $JANX $BMY $MRK https://www.biopharmadive.com/news/janux-bristol-myers-partnership-t-cell-engagers-cancer/810227/ https://www.biopharmadive.com/news/janux-bristol-myers-partnership-t-cell-engagers-cancer/810227/"  
[X Link](https://x.com/BentheFidler/status/2014393357791867261)  2026-01-22T17:42Z [----] followers, [----] engagements


"Sarepta battling slowing sales claims Duchenne gene therapys impact grows with time @ByJonGardner $SRPT + 12% https://www.biopharmadive.com/news/sarepta-elevidys-duchenne-gene-therapy-embark-data/810461/ https://www.biopharmadive.com/news/sarepta-elevidys-duchenne-gene-therapy-embark-data/810461/"  
[X Link](https://x.com/BentheFidler/status/2015833146659373498)  2026-01-26T17:04Z [----] followers, [---] engagements


"FDA lifts hold on an Intellia CRISPR drug trial by @Lilah_Alvarado $NTLA + 10% $ALNY $BBIO $PFE https://www.biopharmadive.com/news/intellia-fda-lifts-hold-nex-z-crispr-ttr-amyloidosis/810584/ https://www.biopharmadive.com/news/intellia-fda-lifts-hold-nex-z-crispr-ttr-amyloidosis/810584/"  
[X Link](https://x.com/BentheFidler/status/2016196376216912284)  2026-01-27T17:07Z [----] followers, [---] engagements


"Drugs for cancer arthritis and HIV on Medicares list for [----] price cuts $LLY $GILD $PFE $NVS https://www.biopharmadive.com/news/medicare-drug-price-2028-trulicity-biktarvy-verzenio-kisqali/810688/ https://www.biopharmadive.com/news/medicare-drug-price-2028-trulicity-biktarvy-verzenio-kisqali/810688/"  
[X Link](https://x.com/BentheFidler/status/2016556602661241333)  2026-01-28T16:58Z [----] followers, [---] engagements


"Lilly bets on Seamless delving further into genetic medicine for hearing loss by @Lilah_Alvarado $LLY $REGN https://www.biopharmadive.com/news/eli-lilly-seamless-deal-gene-editing-hearing-loss/810694/ https://www.biopharmadive.com/news/eli-lilly-seamless-deal-gene-editing-hearing-loss/810694/"  
[X Link](https://x.com/BentheFidler/status/2016631318386237744)  2026-01-28T21:55Z [----] followers, [---] engagements


"Tenpoint wins FDA nod for combination presbyopia eye drop by @gwendolynawu #biotech #startups $ABBV $LENZ https://www.biopharmadive.com/news/tenpoint-yuvezzi-fda-approve-presbyopia-eye-drop/810743/ https://www.biopharmadive.com/news/tenpoint-yuvezzi-fda-approve-presbyopia-eye-drop/810743/"  
[X Link](https://x.com/BentheFidler/status/2016852923423060270)  2026-01-29T12:36Z [----] followers, [---] engagements


"AstraZeneca strengthens China ties with planned $15B investment by Kristin Jensen $AZN #china #biotech https://www.biopharmadive.com/news/astrazeneca-china-biotech-invest-drug-manufacturing/810847/ https://www.biopharmadive.com/news/astrazeneca-china-biotech-invest-drug-manufacturing/810847/"  
[X Link](https://x.com/BentheFidler/status/2016905205623767236)  2026-01-29T16:04Z [----] followers, [---] engagements


"Sanofi expects vaccine sales growth to dip amid challenging environment by @Lilah_Alvarado $SNY https://www.biopharmadive.com/news/sanofi-vaccine-sales-fourth-quarter-2025-earnings/810829/ https://www.biopharmadive.com/news/sanofi-vaccine-sales-fourth-quarter-2025-earnings/810829/"  
[X Link](https://x.com/BentheFidler/status/2016922356770394608)  2026-01-29T17:12Z [----] followers, [---] engagements


"Right after pledging $15B to China $AZN is picking up several #obesity assets via a potentially $18B+ alliance with CSPC https://doc.irasia.com/listco/hk/cspc/announcement/a260130.pdf https://doc.irasia.com/listco/hk/cspc/announcement/a260130.pdf"  
[X Link](https://x.com/BentheFidler/status/2017062565428289810)  2026-01-30T02:29Z [----] followers, [----] engagements


"Moderna holds a garage sale; Roche defends #obesity drug data $MRNA $RHHBY $LLY $SMMT #biotech https://www.biopharmadive.com/news/moderna-recordati-roche-obesity-summit-lilly-repertoire/810853/ https://www.biopharmadive.com/news/moderna-recordati-roche-obesity-summit-lilly-repertoire/810853/"  
[X Link](https://x.com/BentheFidler/status/2017265247770288319)  2026-01-30T15:54Z [----] followers, [---] engagements


"Pfizer dips on new data for #obesity drug acquired in $10B deal @ByJonGardner $PFE - 3% $MTSR $LLY $NVO https://www.biopharmadive.com/news/pfizer-obesity-metsera-phase-2-results-GLP1-monthly-shot/811201/ https://www.biopharmadive.com/news/pfizer-obesity-metsera-phase-2-results-GLP1-monthly-shot/811201/"  
[X Link](https://x.com/BentheFidler/status/2018733773584585160)  2026-02-03T17:10Z [----] followers, [---] engagements


"New: Earnings roundup: Amgen vs. FDA Pfizers defense and Mercks $70B-in-sales plan $AMGN $PFE $MRK #biotech https://www.biopharmadive.com/news/amgen-pfizer-merck-fda-biotech-earnings-q4-2025/811287/ https://www.biopharmadive.com/news/amgen-pfizer-merck-fda-biotech-earnings-q4-2025/811287/"  
[X Link](https://x.com/BentheFidler/status/2019061960038400502)  2026-02-04T14:54Z [----] followers, [---] engagements


"Lilly soars again as fast-selling weight loss drugs top Wall Street projections by Kristin Jensen $LLY + 10% #obesity https://www.biopharmadive.com/news/lilly-earnings-guidance-q4-2025-obesity-drugs/811317/ https://www.biopharmadive.com/news/lilly-earnings-guidance-q4-2025-obesity-drugs/811317/"  
[X Link](https://x.com/BentheFidler/status/2019084288579297495)  2026-02-04T16:23Z [----] followers, [---] engagements


"Novo shares tumble by double digits on grim sales outlook @ByJonGardner $NVO $LLY https://www.biopharmadive.com/news/novo-nordisk-2025-earnings-2026-outlook/811318/ https://www.biopharmadive.com/news/novo-nordisk-2025-earnings-2026-outlook/811318/"  
[X Link](https://x.com/BentheFidler/status/2019092628399075523)  2026-02-04T16:56Z [----] followers, [---] engagements


"Generate an AI-driven Flagship startup pitches an #IPO by Kristin Jensen $GENB #startups #biotech $AZN $AMGN https://www.biopharmadive.com/news/generate-biomedicines-ipo-flagship-ai-tlsp/811482/ https://www.biopharmadive.com/news/generate-biomedicines-ipo-flagship-ai-tlsp/811482/"  
[X Link](https://x.com/BentheFidler/status/2019450111001084259)  2026-02-05T16:36Z [----] followers, [---] engagements


"Novo Lilly sputter as Hims launches knockoff GLP-1 pill $HIMS $LLY - 7% $NVO - 6% #obesity https://www.biopharmadive.com/news/hims-compounded-wegovy-glp-1-obesity-novo-lilly/811476/ https://www.biopharmadive.com/news/hims-compounded-wegovy-glp-1-obesity-novo-lilly/811476/"  
[X Link](https://x.com/BentheFidler/status/2019467346486678015)  2026-02-05T17:45Z [----] followers, [---] engagements


"Evommune nabs $150M in #IPO amid federal shutdown by @gwendolynawu $EVMN https://www.biopharmadive.com/news/evommune-ipo-pricing-chronic-spontaneous-urticaria-hives/804677/ https://www.biopharmadive.com/news/evommune-ipo-pricing-chronic-spontaneous-urticaria-hives/804677/"  
[X Link](https://x.com/BentheFidler/status/1986250448370639306)  2025-11-06T01:53Z [----] followers, [---] engagements


"J&Js remarkable Tecvayli data support earlier use in multiple myeloma @ByJonGardner $JNJ #ASH25 $ACLX $BMY https://www.biopharmadive.com/news/johnson-johnson-tecvayli-darzalex-ash-multiple-myeloma-results/807234/ https://www.biopharmadive.com/news/johnson-johnson-tecvayli-darzalex-ash-multiple-myeloma-results/807234/"  
[X Link](https://x.com/BentheFidler/status/1998371335538667699)  2025-12-09T12:37Z [----] followers, [---] engagements


"BioMarin vets form Mendra to modernize rare disease drug development by Kristin Jensen #biotech #startups $BMRN https://www.biopharmadive.com/news/mendra-rare-disease-biotech-startup-ai-biomarin-financing/810204/ https://www.biopharmadive.com/news/mendra-rare-disease-biotech-startup-ai-biomarin-financing/810204/"  
[X Link](https://x.com/BentheFidler/status/2014383355228262420)  2026-01-22T17:03Z [----] followers, [---] engagements


"Novo climbs higher on strong Wegovy pill launch; Terns tweaks leukemia drug deal $NVO + 2% $TERN $CORT https://www.biopharmadive.com/news/wegovy-pill-prescriptions-terns-deal-corcept-data-biomerieux/810253/ https://www.biopharmadive.com/news/wegovy-pill-prescriptions-terns-deal-corcept-data-biomerieux/810253/"  
[X Link](https://x.com/BentheFidler/status/2014730145559417246)  2026-01-23T16:01Z [----] followers, [---] engagements


"Regenxbio gene therapy trials suspended by FDA over safety worries by Kristin Jensen $RGNX - 17% #GeneTherapy https://www.biopharmadive.com/news/regenxbio-fda-hold-hunter-hurler-syndrome-gene-therapy/810691/ https://www.biopharmadive.com/news/regenxbio-fda-hold-hunter-hurler-syndrome-gene-therapy/810691/"  
[X Link](https://x.com/BentheFidler/status/2016547761261334804)  2026-01-28T16:23Z [----] followers, [----] engagements


"Halozyme buys a #biotech startup; Cytokinetics launches heart drug $HALO $GSK $CYTK https://www.biopharmadive.com/news/halozyme-surf-myqorzo-boehringer-china-gsk-rsv-epidarex/810539/ https://www.biopharmadive.com/news/halozyme-surf-myqorzo-boehringer-china-gsk-rsv-epidarex/810539/"  
[X Link](https://x.com/BentheFidler/status/2016553367082762565)  2026-01-28T16:46Z [----] followers, [---] engagements


"GSK walks away from pioneering Wave RNA editing drug $WVE $KRRO $GSK $BEAM https://www.biopharmadive.com/news/wave-gsk-reacquire-rna-editing-drug-aatd/811067/ https://www.biopharmadive.com/news/wave-gsk-reacquire-rna-editing-drug-aatd/811067/"  
[X Link](https://x.com/BentheFidler/status/2018327404322619658)  2026-02-02T14:15Z [----] followers, [----] engagements


"New: Eikon Therapeutics nets a $381M #IPO amid burst of #biotech offerings by @gwendolynawu $EIKN $MANE $AGMB $SGP https://www.biopharmadive.com/news/eikon-biotech-ipo-price-cancer-drugs-2026/811169/ https://www.biopharmadive.com/news/eikon-biotech-ipo-price-cancer-drugs-2026/811169/"  
[X Link](https://x.com/BentheFidler/status/2019218934118187153)  2026-02-05T01:18Z [----] followers, [----] engagements


"Bayer details anticipated stroke prevention data for new blood-thinner @ByJonGardner $BAYRY $BMY $JNJ $REGN https://www.biopharmadive.com/news/bayer-asundexian-factorXIa-secondary-stroke-data-conference/811455/ https://www.biopharmadive.com/news/bayer-asundexian-factorXIa-secondary-stroke-data-conference/811455/"  
[X Link](https://x.com/BentheFidler/status/2019460585855857058)  2026-02-05T17:18Z [----] followers, [---] engagements


"Earnings roundup: AbbVie angst a bifurcated vaccine market and Bristol Myers waiting game by @realJacobBell and @Lilah_Alvarado #biotech $ABBV $BMY $GSK https://www.biopharmadive.com/news/bristol-myers-abbvie-gsk-vaccines-biotech-earnings-q4-2025/811463/ https://www.biopharmadive.com/news/bristol-myers-abbvie-gsk-vaccines-biotech-earnings-q4-2025/811463/"  
[X Link](https://x.com/BentheFidler/status/2019530044201398698)  2026-02-05T21:54Z [----] followers, [---] engagements


"Agomab SpyGlass bank a combined $350M in biotech IPOs by @gwendolynawu $AGMB $SGP $MANE $EIKN #IPO https://www.biopharmadive.com/news/agomab-spyglass-biotech-ipo-price-2026/811385/ https://www.biopharmadive.com/news/agomab-spyglass-biotech-ipo-price-2026/811385/"  
[X Link](https://x.com/BentheFidler/status/2019584737892003900)  2026-02-06T01:31Z [----] followers, [---] engagements


"RT @ScottGottliebMD: My Op Ed in Today's @PostOpinions "The long-lasting effects of viruses and the anti-vaccine movement. For some peopl"  
[X Link](https://x.com/BentheFidler/status/2019790639844528373)  2026-02-06T15:09Z [----] followers, [--] engagements


"White Houses online service for drug sales debuts with limited impact on prices @ByJonGardner https://www.biopharmadive.com/news/trump-rx-drug-prices-discount-white-house/811576/ https://www.biopharmadive.com/news/trump-rx-drug-prices-discount-white-house/811576/"  
[X Link](https://x.com/anyuser/status/2019822995712462879)  2026-02-06T17:18Z [----] followers, [---] engagements


"Hims cancels plans to sell compounded GLP-1 pill after FDA backlash $HIMS $NVO #obesity https://www.biopharmadive.com/news/hims-stop-launch-compounded-wegovy-fda-novo/811662/ https://www.biopharmadive.com/news/hims-stop-launch-compounded-wegovy-fda-novo/811662/"  
[X Link](https://x.com/BentheFidler/status/2020305414894866524)  2026-02-08T01:15Z [----] followers, [---] engagements


"Updated w/ news of Novo's lawsuit: Hims cancels plans to sell compounded GLP-1 pill after FDA backlash $HIMS $NVO #obesity https://www.biopharmadive.com/news/hims-stop-launch-compounded-wegovy-fda-novo/811662/ https://www.biopharmadive.com/news/hims-stop-launch-compounded-wegovy-fda-novo/811662/"  
[X Link](https://x.com/BentheFidler/status/2020846780795990375)  2026-02-09T13:06Z [----] followers, [---] engagements


"Takeda Iambic partner in latest pharma AI push by @realJacobBell $TAK @iambic_ai #biotech https://www.biopharmadive.com/news/takeda-iambic-ai-drug-discovery-deal-biotech/811643/ https://www.biopharmadive.com/news/takeda-iambic-ai-drug-discovery-deal-biotech/811643/"  
[X Link](https://x.com/BentheFidler/status/2020847518901223796)  2026-02-09T13:09Z [----] followers, [---] engagements


"Lilly bets again on China drugs; Roche showcases MS data $LLY $RHHBY $ROIV $GILD https://www.biopharmadive.com/news/lilly-bets-again-on-china-drugs-roche-showcases-ms-data/811669/ https://www.biopharmadive.com/news/lilly-bets-again-on-china-drugs-roche-showcases-ms-data/811669/"  
[X Link](https://x.com/BentheFidler/status/2020908594019885381)  2026-02-09T17:12Z [----] followers, [---] engagements


"Lilly buys in vivo CAR-T maker Orna extending streak of genetic medicine deals @ByJonGardner $LLY $BMY $GILD $AZN $ABBV https://www.biopharmadive.com/news/lilly-orna-acquire-in-vivo-cell-therapy-autoimmune/811692/ https://www.biopharmadive.com/news/lilly-orna-acquire-in-vivo-cell-therapy-autoimmune/811692/"  
[X Link](https://x.com/BentheFidler/status/2020910529414418775)  2026-02-09T17:19Z [----] followers, [---] engagements


"Hengrui Kailera tout positive results for dual-acting obesity pill by @Lilah_Alvarado #obesity $LLY $NVO https://www.biopharmadive.com/news/kailera-hengrui-oral-ribupatide-study-results-china/811718/ https://www.biopharmadive.com/news/kailera-hengrui-oral-ribupatide-study-results-china/811718/"  
[X Link](https://x.com/BentheFidler/status/2021212257124757604)  2026-02-10T13:18Z [----] followers, [---] engagements


"FDA rejects Regenxbio treatment in another blow to gene therapy by @gwendolynawu $RGNX - 14% #GeneTherapy https://www.biopharmadive.com/news/regenxbio-fda-reject-gene-therapy-mps-hunter-syndrome/811775/ https://www.biopharmadive.com/news/regenxbio-fda-reject-gene-therapy-mps-hunter-syndrome/811775/"  
[X Link](https://x.com/BentheFidler/status/2021269170311020802)  2026-02-10T17:04Z [----] followers, [---] engagements


"Nektar continuing comeback says eczema drugs effects hold up in follow-up study @ByJonGardner $NKTR + 43% $REGN $CRVS $SNY https://www.biopharmadive.com/news/nektar-rezpegaldesleukin-eczema-maintenance-data-results/811806/ https://www.biopharmadive.com/news/nektar-rezpegaldesleukin-eczema-maintenance-data-results/811806/"  
[X Link](https://x.com/BentheFidler/status/2021271863456919687)  2026-02-10T17:15Z [----] followers, [---] engagements


"Gilead dips as strong earnings outweighed by high expectations for new HIV drug by @realJacobBell $GILD - 2% https://www.biopharmadive.com/news/gilead-yeztugo-earnings-q4-full-year-hiv-sales/811908/ https://www.biopharmadive.com/news/gilead-yeztugo-earnings-q4-full-year-hiv-sales/811908/"  
[X Link](https://x.com/BentheFidler/status/2021568405183013131)  2026-02-11T12:54Z [----] followers, [---] engagements


"FDA refuses to review Modernas mRNA flu vaccine by @Lilah_Alvarado $MRNA - 10% https://www.biopharmadive.com/news/moderna-fda-influenza-mrna-refuse-to-file/811909/ https://www.biopharmadive.com/news/moderna-fda-influenza-mrna-refuse-to-file/811909/"  
[X Link](https://x.com/anyuser/status/2021580109942026355)  2026-02-11T13:40Z [----] followers, [---] engagements


"Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill $EVMN $AZN $UPB - 51% $MRNA $TAK #biotech https://www.biopharmadive.com/news/evommune-eczema-astrazeneca-obesity-upstream-takeda-oveporexton-moderna/811791/ https://www.biopharmadive.com/news/evommune-eczema-astrazeneca-obesity-upstream-takeda-oveporexton-moderna/811791/"  
[X Link](https://x.com/BentheFidler/status/2021615569485570179)  2026-02-11T16:01Z [----] followers, [---] engagements


"Madrigal turns to RNAi drugs from China to bolster MASH pipeline by Kristin Jensen $MDGL https://www.biopharmadive.com/news/madrigal-suzhou-ribo-mash-rnai-drug-deal-china/811920/ https://www.biopharmadive.com/news/madrigal-suzhou-ribo-mash-rnai-drug-deal-china/811920/"  
[X Link](https://x.com/BentheFidler/status/2021616917136777648)  2026-02-11T16:06Z [----] followers, [---] engagements


"BridgeBio scores with dwarfism drug setting up showdown with BioMarin Ascendis by @realJacobBell $BBIO $ASND $BMRN https://www.biopharmadive.com/news/bridgebio-dwarfism-drug-data-infigratinib-achondroplasia-biomarin-ascendis/812034/ https://www.biopharmadive.com/news/bridgebio-dwarfism-drug-data-infigratinib-achondroplasia-biomarin-ascendis/812034/"  
[X Link](https://x.com/anyuser/status/2021928097063612497)  2026-02-12T12:43Z [----] followers, [---] engagements


"Updated w/ more details: BridgeBio scores with dwarfism drug setting up showdown with BioMarin Ascendis by @realJacobBell $BBIO + 15% $BMRN - 5% $ASND - 4% https://www.biopharmadive.com/news/bridgebio-dwarfism-drug-data-infigratinib-achondroplasia-biomarin-ascendis/812034/ https://www.biopharmadive.com/news/bridgebio-dwarfism-drug-data-infigratinib-achondroplasia-biomarin-ascendis/812034/"  
[X Link](https://x.com/BentheFidler/status/2021949478891319710)  2026-02-12T14:08Z [----] followers, [---] engagements


"Sanofi looking for more rigor swaps CEO Hudson for ex-Merck KGaA chief Garijo by Kristin Jensen $SNY - 4% $MKKGY https://www.biopharmadive.com/news/sanofi-ceo-paul-hudson-belen-garijo/812061/ https://www.biopharmadive.com/news/sanofi-ceo-paul-hudson-belen-garijo/812061/"  
[X Link](https://x.com/BentheFidler/status/2021980778746556507)  2026-02-12T16:12Z [----] followers, [---] engagements


"Seres to lay off staff pause top program in latest reboot by @Lilah_Alvarado $MCRB - 37% https://www.biopharmadive.com/news/seres-layoffs-restructuring-microbiome-immune-disease/812079/ https://www.biopharmadive.com/news/seres-layoffs-restructuring-microbiome-immune-disease/812079/"  
[X Link](https://x.com/BentheFidler/status/2021994250968400146)  2026-02-12T17:06Z [----] followers, [---] engagements


"Earnings roundup: Neurocrine slumps Alnylam battles skeptics and Ascendis eyes a competitor by @realJacobBell $NBIX - 10% $ALNY - 4% $ASND - 2% $BBIO #biotech https://www.biopharmadive.com/news/alnylam-neurocrine-ascendis-biotech-earnings-4q-2025/812137/ https://www.biopharmadive.com/news/alnylam-neurocrine-ascendis-biotech-earnings-4q-2025/812137/"  
[X Link](https://x.com/BentheFidler/status/2022075043048829325)  2026-02-12T22:27Z [----] followers, [---] engagements


"Regeneron cancer bispecific rejected again; Allogene discloses trial death $ALLO $REGN $ARGX $BIIB $BMY https://www.biopharmadive.com/news/regeneron-odronextamab-crl-allogene-patient-death-bristol-myers-earnings/756464/ https://www.biopharmadive.com/news/regeneron-odronextamab-crl-allogene-patient-death-bristol-myers-earnings/756464/"  
[X Link](https://x.com/BentheFidler/status/1951300538051563721)  2025-08-01T15:14Z [----] followers, [---] engagements


"Vertex plan to build on pain drug breakthrough hits hurdles by @NedPagliarulo $VRTX - 14% https://www.biopharmadive.com/news/vertex-pain-neuropathic-delay-vx-993-negative-trial/756753/ https://www.biopharmadive.com/news/vertex-pain-neuropathic-delay-vx-993-negative-trial/756753/"  
[X Link](https://x.com/BentheFidler/status/1952679295635108094)  2025-08-05T10:33Z [----] followers, [---] engagements


"New: US #biotech needs government support to match Chinas gains Pfizer CEO says $PFE https://www.biopharmadive.com/news/china-biotech-drug-deals-pfizer-bourla-comments/756880/ https://www.biopharmadive.com/news/china-biotech-drug-deals-pfizer-bourla-comments/756880/"  
[X Link](https://x.com/BentheFidler/status/1952899358061674804)  2025-08-06T01:07Z [----] followers, [---] engagements


"Nxera debuts an obesity pipeline; BridgeBio battles Alynam for market share $BBIO - 11% $ALNY $MDGL $MCRB $BMRN https://www.biopharmadive.com/news/nxera-glp-1-bridgebio-attruby-madrigal-rezdiffra-sales/756914/ https://www.biopharmadive.com/news/nxera-glp-1-bridgebio-attruby-madrigal-rezdiffra-sales/756914/"  
[X Link](https://x.com/BentheFidler/status/1953121294498578691)  2025-08-06T15:49Z [----] followers, [---] engagements


"Novo pushes back against obesity drug compounders as competition intensifies @ByJonGardner $NVO $LLY https://www.biopharmadive.com/news/novo-nordisk-wegovy-obesity-compounders-second-quarter-2025-earnings/756916/ https://www.biopharmadive.com/news/novo-nordisk-wegovy-obesity-compounders-second-quarter-2025-earnings/756916/"  
[X Link](https://x.com/BentheFidler/status/1953134970710475094)  2025-08-06T16:43Z [----] followers, [---] engagements


"Iovance cuts staff amid slow sales start for TIL cell therapy $IOVA https://www.biopharmadive.com/news/iovance-layoffs-restructuring-amtagvi-sales-guidance/757041/ https://www.biopharmadive.com/news/iovance-layoffs-restructuring-amtagvi-sales-guidance/757041/"  
[X Link](https://x.com/BentheFidler/status/1953457021480534517)  2025-08-07T14:03Z [----] followers, [---] engagements


"Arvinas Pfizer reworking partnership on Protac cancer drug by Kristin Jensen $ARVN $PFE https://www.biopharmadive.com/news/arvinas-pfizer-vepdegestrant-partnership-rework-breast-cancer/757043/ https://www.biopharmadive.com/news/arvinas-pfizer-vepdegestrant-partnership-rework-breast-cancer/757043/"  
[X Link](https://x.com/BentheFidler/status/1953479559166210326)  2025-08-07T15:33Z [----] followers, [--] engagements


"Strand raises another $153M to make programmable mRNA drugs by @gwendolynawu #biotech #startups https://www.biopharmadive.com/news/strand-series-b-mrna-cancer-jake-becraft/757101/ https://www.biopharmadive.com/news/strand-series-b-mrna-cancer-jake-becraft/757101/"  
[X Link](https://x.com/BentheFidler/status/1953556752630165605)  2025-08-07T20:39Z [----] followers, [---] engagements


"Expedition a startup searching for drugs from China cuts its first deal $AZN $INSM #biotech #startups https://www.biopharmadive.com/news/expedition-fosun-china-licensing-deal-dpp1-biotech-startup/757394/ https://www.biopharmadive.com/news/expedition-fosun-china-licensing-deal-dpp1-biotech-startup/757394/"  
[X Link](https://x.com/BentheFidler/status/1955263612961902728)  2025-08-12T13:42Z [----] followers, [---] engagements


"Pfizer looks to expand ADC use after positive bladder cancer data @ByJonGardner $PFE $MRK https://www.biopharmadive.com/news/padcev-keytruda-neoadjuvant-adjuvant-bladder-cancer-positive-data-pfizer-merck/757441/ https://www.biopharmadive.com/news/padcev-keytruda-neoadjuvant-adjuvant-bladder-cancer-positive-data-pfizer-merck/757441/"  
[X Link](https://x.com/BentheFidler/status/1955302837325353284)  2025-08-12T16:18Z [----] followers, [---] engagements


"Vor says drug licensed from RemeGen succeeded in Sjgrens study by @NedPagliarulo $VOR + 18% $NVS $VRTX $VERA https://www.biopharmadive.com/news/remegen-vor-telitacicept-sjorgens-phase-3-study/757532/ https://www.biopharmadive.com/news/remegen-vor-telitacicept-sjorgens-phase-3-study/757532/"  
[X Link](https://x.com/BentheFidler/status/1955649389331882223)  2025-08-13T15:15Z [----] followers, [---] engagements


"Vedanta PureTechs microbiome #startup to cut staff after study setback $MCRB $JNJ $PRTC https://www.biopharmadive.com/news/vedanta-layoffs-ulcerative-colitis-study-results-microbiome-puretech/757650/ https://www.biopharmadive.com/news/vedanta-layoffs-ulcerative-colitis-study-results-microbiome-puretech/757650/"  
[X Link](https://x.com/BentheFidler/status/1955986862163579002)  2025-08-14T13:36Z [----] followers, [---] engagements


"Lilly says it will raise drug prices in Europe responding to Trump threats @ByJonGardner $LLY https://www.biopharmadive.com/news/lilly-drug-prices-europe-most-favored-nation-uk-mounjaro/757704/ https://www.biopharmadive.com/news/lilly-drug-prices-europe-most-favored-nation-uk-mounjaro/757704/"  
[X Link](https://x.com/BentheFidler/status/1956076156979175709)  2025-08-14T19:31Z [----] followers, [---] engagements


"Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial $PGEN $PFE $LLY $AUTL $GBIO https://www.biopharmadive.com/news/precigen-approval-prasad-pfizer-inclacumab-sickle-cell-lilly-superluminal/757738/ https://www.biopharmadive.com/news/precigen-approval-prasad-pfizer-inclacumab-sickle-cell-lilly-superluminal/757738/"  
[X Link](https://x.com/BentheFidler/status/1956379813381378500)  2025-08-15T15:37Z [----] followers, [---] engagements


"Novos Wegovy becomes first GLP-1 drug approved for MASH $NVO + 4% $MDGL - 5% https://www.biopharmadive.com/news/novo-wegovy-mash-fda-approval-rezdiffra-madrigal/757853/ https://www.biopharmadive.com/news/novo-wegovy-mash-fda-approval-rezdiffra-madrigal/757853/"  
[X Link](https://x.com/BentheFidler/status/1957430686387695667)  2025-08-18T13:13Z [----] followers, [---] engagements


"Breaking: FDA approves Ionis hereditary angioedema drug by @gwendolynawu $IONS $BCRX $NTLA https://www.biopharmadive.com/news/ionis-donidalorsen-dawnzera-hereditary-angioedema-approval-fda/758195/ https://www.biopharmadive.com/news/ionis-donidalorsen-dawnzera-hereditary-angioedema-approval-fda/758195/"  
[X Link](https://x.com/BentheFidler/status/1958561387556307117)  2025-08-21T16:06Z [----] followers, [----] engagements


"Gilead dives into in vivo cell therapy with $350M buyout of Interius @ByJonGardner $GILD $ABBV $AZN https://www.biopharmadive.com/news/gilead-interius-acquire-in-vivo-cell-therapy/758266/ https://www.biopharmadive.com/news/gilead-interius-acquire-in-vivo-cell-therapy/758266/"  
[X Link](https://x.com/BentheFidler/status/1958562305429348743)  2025-08-21T16:10Z [----] followers, [---] engagements


"Over [----] HHS employees call on RFK Jr. to step down by @RebeccaMPifer https://www.biopharmadive.com/news/hhs-staff-letter-rfk-jr-kennedy-resign-cdc-monarez/759133/ https://www.biopharmadive.com/news/hhs-staff-letter-rfk-jr-kennedy-resign-cdc-monarez/759133/"  
[X Link](https://x.com/BentheFidler/status/1963271523269038201)  2025-09-03T16:03Z [----] followers, [---] engagements


"Sanofis touted eczema drug hits study goal but data fall short of expectations by Kristin Jensen $SNY - 8% $AMGN https://www.biopharmadive.com/news/sanofi-amlitelimab-eczema-atopic-dermatitis-study-results-disappoint-analysts/759231/ https://www.biopharmadive.com/news/sanofi-amlitelimab-eczema-atopic-dermatitis-study-results-disappoint-analysts/759231/"  
[X Link](https://x.com/BentheFidler/status/1963622424634708112)  2025-09-04T15:17Z [----] followers, [---] engagements


"At Senate hearing lawmakers express dissatisfaction with RFK Jr.s vaccine moves by @Lilah_Alvarado and @ByJonGardner https://www.biopharmadive.com/news/kennedy-rfk-senate-hearing-vaccines-cdc-crisis-acip/759319/ https://www.biopharmadive.com/news/kennedy-rfk-senate-hearing-vaccines-cdc-crisis-acip/759319/"  
[X Link](https://x.com/BentheFidler/status/1963698751090180140)  2025-09-04T20:20Z [----] followers, [---] engagements


"A UK #biotech takes aim at Parkinsons ALS by drugging mitochondria by @gwendolynawu #startups https://www.biopharmadive.com/news/nrg-therapeutics-series-b-parkinsons-als-mitochondria-mptp/759403/ https://www.biopharmadive.com/news/nrg-therapeutics-series-b-parkinsons-als-mitochondria-mptp/759403/"  
[X Link](https://x.com/BentheFidler/status/1965084384501059814)  2025-09-08T16:06Z [----] followers, [---] engagements


"Novo Nordisk to lay off [----] workers in major restructuring by Kristin Jensen $NVO $LLY https://www.biopharmadive.com/news/novo-nordisk-layoffs-restructuring-obesity-drug-competition/759748/ https://www.biopharmadive.com/news/novo-nordisk-layoffs-restructuring-obesity-drug-competition/759748/"  
[X Link](https://x.com/BentheFidler/status/1965794136331800975)  2025-09-10T15:06Z [----] followers, [----] engagements


"Kriya Odyssey secure megarounds; Amgen boosts R&D leadership #startups #IPO $AMGN $DNTH $MRK https://www.biopharmadive.com/news/kriya-odyssey-megarounds-amgen-research-leadership-dianthus-gmg/759723/ https://www.biopharmadive.com/news/kriya-odyssey-megarounds-amgen-research-leadership-dianthus-gmg/759723/"  
[X Link](https://x.com/BentheFidler/status/1965807433881915690)  2025-09-10T15:59Z [----] followers, [---] engagements


"FDA clears J&Js drug-device combo for bladder cancer @ByJonGardner $JNJ $CGON https://www.biopharmadive.com/news/fda-inlexzo-approval-johnson-johnson-bladder-cancer/759727/ https://www.biopharmadive.com/news/fda-inlexzo-approval-johnson-johnson-bladder-cancer/759727/"  
[X Link](https://x.com/BentheFidler/status/1965808283593347347)  2025-09-10T16:03Z [----] followers, [----] engagements


"Novartis dives deeper into protein degraders with second Monte Rosa deal $NVS $GLUE + 42% https://www.biopharmadive.com/news/novartis-monte-rosa-molecular-glue-degrader-partnership-immune-drugs/760084/ https://www.biopharmadive.com/news/novartis-monte-rosa-molecular-glue-degrader-partnership-immune-drugs/760084/"  
[X Link](https://x.com/BentheFidler/status/1967585762737852889)  2025-09-15T13:46Z [----] followers, [---] engagements


"Former CinCor execs reunite to helm new #biotech #startup by @gwendolynawu $SNY https://www.biopharmadive.com/news/allrock-bio-cincor-sanofi-rock-inhibitor/760043/ https://www.biopharmadive.com/news/allrock-bio-cincor-sanofi-rock-inhibitor/760043/"  
[X Link](https://x.com/BentheFidler/status/1967931060538519946)  2025-09-16T12:38Z [----] followers, [---] engagements


"Ollin debuts with $100M and plans to challenge top-selling eye drugs by @gwendolynawu #biotech #startups $AMGN $RHHBY $REGN https://www.biopharmadive.com/news/ollin-biosciences-ophthalmology-startup-vabysmo-tepezza/760182/ https://www.biopharmadive.com/news/ollin-biosciences-ophthalmology-startup-vabysmo-tepezza/760182/"  
[X Link](https://x.com/BentheFidler/status/1968261955367612906)  2025-09-17T10:33Z [----] followers, [---] engagements


"GSK ups US investment with $30B spending plan by @NedPagliarulo $GSK https://www.biopharmadive.com/news/gsk-us-manufacturing-investment-30-billion-pennsylvania/760366/ https://www.biopharmadive.com/news/gsk-us-manufacturing-investment-30-billion-pennsylvania/760366/"  
[X Link](https://x.com/BentheFidler/status/1968341578789110205)  2025-09-17T15:49Z [----] followers, [---] engagements


"Roivant pill succeeds in rare inflammatory disease trial @ByJonGardner $ROIV + 10% https://www.biopharmadive.com/news/roivant-pfizer-brepocitinib-trial-dermatomyositis/760368/ https://www.biopharmadive.com/news/roivant-pfizer-brepocitinib-trial-dermatomyositis/760368/"  
[X Link](https://x.com/BentheFidler/status/1968342218936320200)  2025-09-17T15:52Z [----] followers, [---] engagements


"Roche dives into MASH with $2.4B deal for 89bio $ETNB $AKRO $GSK $NVO $RHHBY https://www.biopharmadive.com/news/roche-89bio-deal-acquire-mash-drug-fgf21-pegozafermin/760483/ https://www.biopharmadive.com/news/roche-89bio-deal-acquire-mash-drug-fgf21-pegozafermin/760483/"  
[X Link](https://x.com/BentheFidler/status/1968684936107299278)  2025-09-18T14:33Z [----] followers, [---] engagements


"Biogen to buy startup Alcyone eyeing easier delivery of RNA drugs by Kristin Jensen $BIIB $IONS https://www.biopharmadive.com/news/biogen-alcyone-acquire-drug-delivery-brain-antisense-oligonucleotides/760504/ https://www.biopharmadive.com/news/biogen-alcyone-acquire-drug-delivery-brain-antisense-oligonucleotides/760504/"  
[X Link](https://x.com/BentheFidler/status/1968693998895133010)  2025-09-18T15:10Z [----] followers, [---] engagements


"Arvinas reboots cuts more staff; Porges joins Lazard $ARVN $PFE $REGN $VRTX https://www.biopharmadive.com/news/arvinas-pfizer-out-license-porges-lazard-vertex-casgevy-italy/760567/ https://www.biopharmadive.com/news/arvinas-pfizer-out-license-porges-lazard-vertex-casgevy-italy/760567/"  
[X Link](https://x.com/BentheFidler/status/1969059729440649497)  2025-09-19T15:23Z [----] followers, [---] engagements


"Pfizer buys back into obesity drug chase with $4.9B Metsera deal @ByJonGardner $MTSR $PFE $LLY $NVO https://www.biopharmadive.com/news/pfizer-metsera-acquire-obesity-drugs-glp1-amylin/760719/ https://www.biopharmadive.com/news/pfizer-metsera-acquire-obesity-drugs-glp1-amylin/760719/"  
[X Link](https://x.com/BentheFidler/status/1970157330869498342)  2025-09-22T16:04Z [----] followers, [---] engagements


"Capricor readies revised FDA pitch for #Duchenne cell therapy by Kristin Jensen $CAPR + 8% https://www.biopharmadive.com/news/capricor-resubmit-fda-deramiocel-duchenne-cardiomyopathy/761088/ https://www.biopharmadive.com/news/capricor-resubmit-fda-deramiocel-duchenne-cardiomyopathy/761088/"  
[X Link](https://x.com/BentheFidler/status/1971226322044322166)  2025-09-25T14:52Z [----] followers, [---] engagements


"Lillys oral SERD gets FDA nod in advanced breast cancer $LLY $ARVN $PFE $RHHBY $AZN https://www.biopharmadive.com/news/eli-lilly-fda-approve-inluriyo-breast-cancer-oral-serd/761188/ https://www.biopharmadive.com/news/eli-lilly-fda-approve-inluriyo-breast-cancer-oral-serd/761188/"  
[X Link](https://x.com/BentheFidler/status/1971313813002805758)  2025-09-25T20:40Z [----] followers, [---] engagements


"Star raises another $125M for its blood disease drug by @gwendolynawu #biotech #startups $RHHBY https://www.biopharmadive.com/news/star-therapeutics-von-willebrand-series-d/761286/ https://www.biopharmadive.com/news/star-therapeutics-von-willebrand-series-d/761286/"  
[X Link](https://x.com/BentheFidler/status/1972991821036040639)  2025-09-30T11:48Z [----] followers, [---] engagements


"Crystalys debuts with $205M and plans for a better gout drug by @gwendolynawu #biotech #startups $AMGN $ESALF https://www.biopharmadive.com/news/crystalys-gout-drug-dotinurad-startup-launch/761383/ https://www.biopharmadive.com/news/crystalys-gout-drug-dotinurad-startup-launch/761383/"  
[X Link](https://x.com/BentheFidler/status/1973003707722891691)  2025-09-30T12:35Z [----] followers, [---] engagements


"As shutdown begins FDA to stop accepting new drug submissions by Kristin Jensen https://www.biopharmadive.com/news/fda-government-shutdown-new-drug-applications-reviews/761576/ https://www.biopharmadive.com/news/fda-government-shutdown-new-drug-applications-reviews/761576/"  
[X Link](https://x.com/BentheFidler/status/1973392253151232356)  2025-10-01T14:19Z [----] followers, [---] engagements


"Amgen claims landmark study result that could widen heart drugs use @ByJonGardner $AMGN $REGN $MRK $AZN https://www.biopharmadive.com/news/amgen-repatha-primary-prevention-vesalius-results-pcsk9/801795/ https://www.biopharmadive.com/news/amgen-repatha-primary-prevention-vesalius-results-pcsk9/801795/"  
[X Link](https://x.com/BentheFidler/status/1973780982559043801)  2025-10-02T16:03Z [----] followers, [---] engagements


"Peter Marks former top FDA vaccine official joins Eli Lilly @ByJonGardner $LLY https://www.biopharmadive.com/news/peter-marks-eli-lilly-fda-infectious-disease-discovery/802258/ https://www.biopharmadive.com/news/peter-marks-eli-lilly-fda-infectious-disease-discovery/802258/"  
[X Link](https://x.com/BentheFidler/status/1975658054881345654)  2025-10-07T20:22Z [----] followers, [---] engagements


"Venture firms pour $101M into a #biotech using the brain to fix the immune system by @realJacobBell #startups https://www.biopharmadive.com/news/nilo-launch-biotech-column-brain-immune-lux-gates-zuker/802339/ https://www.biopharmadive.com/news/nilo-launch-biotech-column-brain-immune-lux-gates-zuker/802339/"  
[X Link](https://x.com/BentheFidler/status/1975958882045632943)  2025-10-08T16:18Z [----] followers, [---] engagements


"A regenerative therapy for hair loss attracts a mega-fundraising round by @realJacobBell #biotech #startups https://www.biopharmadive.com/news/pelage-hair-loss-therapy-drug-fundraise-series-b-arch-gv/802857/ https://www.biopharmadive.com/news/pelage-hair-loss-therapy-drug-fundraise-series-b-arch-gv/802857/"  
[X Link](https://x.com/BentheFidler/status/1978493929466048656)  2025-10-15T16:11Z [----] followers, [---] engagements


"J&J Cuts Ribbon on Boston Innovation Center Touts Startup Deals http://t.co/mnV1gIbDzt $JNJ http://www.xconomy.com/boston/2013/06/27/jj-cuts-ribbon-on-boston-innovation-center/ http://www.xconomy.com/boston/2013/06/27/jj-cuts-ribbon-on-boston-innovation-center/"  
[X Link](https://x.com/BentheFidler/status/350214848585547776)  2013-06-27T11:31Z [----] followers, [--] engagements


"Alnylams Amyloidosis Drug Holds up in Second Clinical Trial http://t.co/TLJdtkwLbr $ALNY http://www.xconomy.com/boston/2013/07/01/alnylams-amyloidosis-drug-holds-up-in-second-clinical-trial/ http://www.xconomy.com/boston/2013/07/01/alnylams-amyloidosis-drug-holds-up-in-second-clinical-trial/"  
[X Link](https://x.com/BentheFidler/status/351695542721576962)  2013-07-01T13:35Z [----] followers, [--] engagements


"East Coast Life Sciences Roundup: Verdine Vedanta Alnylam & More http://t.co/QJl5aXOcgI $SNY $JNJ $ALNY $INSM $NVS $EPZM $ACHN $CELG http://www.xconomy.com/boston/2013/07/05/east-coast-life-sciences-roundup-verdine-vedanta-alnylam-more/ http://www.xconomy.com/boston/2013/07/05/east-coast-life-sciences-roundup-verdine-vedanta-alnylam-more/"  
[X Link](https://x.com/BentheFidler/status/353115079144771584)  2013-07-05T11:36Z [----] followers, [--] engagements


"New Enterprise Associates Sets up Shop in Kendall Square http://t.co/wkumrBKm9H @NEAVC http://www.xconomy.com/boston/2013/11/14/new-enterprise-associates-sets-shop-kendall-square/ http://www.xconomy.com/boston/2013/11/14/new-enterprise-associates-sets-shop-kendall-square/"  
[X Link](https://x.com/BentheFidler/status/400965713671626753)  2013-11-14T12:37Z [----] followers, [--] engagements


"East Coast Biotech Roundup: Gerngross Akili Intercept & More http://t.co/6QyvbXJ8wf $PFE $ICPT $BIIB $SGMO $MDT $EPZM $ARNI $IRWD http://www.xconomy.com/boston/2014/01/10/east-coast-biotech-roundup-gerngross-akili-intercept-more/ http://www.xconomy.com/boston/2014/01/10/east-coast-biotech-roundup-gerngross-akili-intercept-more/"  
[X Link](https://x.com/BentheFidler/status/421622280171438080)  2014-01-10T12:39Z [----] followers, [--] engagements


"Alnylam Wheels Deals and Gets $700M Investment From Genzyme http://t.co/3ibpot3Wxd $ALNY http://www.xconomy.com/boston/2014/01/13/alnylam-wheels-deals-and-gets-700m-investment-from-genzyme/ http://www.xconomy.com/boston/2014/01/13/alnylam-wheels-deals-and-gets-700m-investment-from-genzyme/"  
[X Link](https://x.com/BentheFidler/status/422626749973684224)  2014-01-13T07:10Z [----] followers, [--] engagements


"East Coast Biotech Roundup: Genocea Eleven NIH/Pharma & More http://t.co/e6SQkqwhHN $GNCA $EBIO $PFE $BMY $BIIB $MRK $AMGN $INCY $AGIO http://www.xconomy.com/boston/2014/02/07/east-coast-biotech-roundup-genocea-eleven-nihpharma-more/ http://www.xconomy.com/boston/2014/02/07/east-coast-biotech-roundup-genocea-eleven-nihpharma-more/"  
[X Link](https://x.com/BentheFidler/status/431777643910791168)  2014-02-07T13:13Z [----] followers, [--] engagements


"East Coast Biotech Roundup: Neurophage Boston Biotech Insmed & More http://t.co/A90wNW4vIw $GILD $INSM $BIIB $SNDX $ALNY $RTRX $BLUE http://www.xconomy.com/boston/2014/03/28/east-coast-biotech-roundup-neurophage-boston-biotech-insmed-more/ http://www.xconomy.com/boston/2014/03/28/east-coast-biotech-roundup-neurophage-boston-biotech-insmed-more/"  
[X Link](https://x.com/BentheFidler/status/449517022670381056)  2014-03-28T12:03Z [----] followers, [--] engagements


"East Coast Biotech Roundup: Sarepta Alkermes Boston Biotech & More http://t.co/1LIAxjADm3 $SRPT $ALKS $ALNY $CBST $ZFGN $CELG $ENTA http://www.xconomy.com/boston/2014/04/25/east-coast-biotech-roundup-sarepta-alkermes-boston-biotech-more/ http://www.xconomy.com/boston/2014/04/25/east-coast-biotech-roundup-sarepta-alkermes-boston-biotech-more/"  
[X Link](https://x.com/BentheFidler/status/459656964989927425)  2014-04-25T11:35Z [----] followers, [--] engagements


"John Maraganore: From "Prototypical Geek" To Canny @Alnylam Chief http://t.co/ZqSpgB4xgc #biotech $ALNY http://www.xconomy.com/boston/2014/09/07/john-maraganore-from-prototypical-geek-to-canny-alnylam-chief/ http://www.xconomy.com/boston/2014/09/07/john-maraganore-from-prototypical-geek-to-canny-alnylam-chief/"  
[X Link](https://x.com/BentheFidler/status/508940948659646465)  2014-09-08T11:32Z [----] followers, [--] engagements


"Alkermes Spinoff Civitas Poised for IPO Sells to Acorda for $525M http://t.co/2pmIhThaBf $ACOR $ALKS $CVTS http://www.xconomy.com/boston/2014/09/24/alkermes-spinoff-civitas-poised-for-ipo-sells-to-acorda-for-525m/ http://www.xconomy.com/boston/2014/09/24/alkermes-spinoff-civitas-poised-for-ipo-sells-to-acorda-for-525m/"  
[X Link](https://x.com/BentheFidler/status/514781710911684608)  2014-09-24T14:21Z [----] followers, [--] engagements


"East Coast Biotech Roundup: Agios Vertex Epizyme Celldex & More http://t.co/R2ATNizkd9 $AGIO $CLDX $EPZM $FOLD $BIND $DRNA $REGN http://www.xconomy.com/boston/2014/11/21/east-coast-biotech-roundup-agios-vertex-epizyme-celldex-more/ http://www.xconomy.com/boston/2014/11/21/east-coast-biotech-roundup-agios-vertex-epizyme-celldex-more/"  
[X Link](https://x.com/BentheFidler/status/535801096594128897)  2014-11-21T14:25Z [----] followers, [--] engagements


"East Coast Biotech Roundup: Yumanity Padlock CAR-T Fever & More http://t.co/5QlaNKQCOc $JUNO $BLCM $VRTX $CELG $BLUE $TTPH $CBST $NPSP http://www.xconomy.com/boston/2014/12/19/east-coast-biotech-roundup-yumanity-padlock-car-t-fever-more/ http://www.xconomy.com/boston/2014/12/19/east-coast-biotech-roundup-yumanity-padlock-car-t-fever-more/"  
[X Link](https://x.com/BentheFidler/status/545949121308139520)  2014-12-19T14:29Z [----] followers, [--] engagements


"Yes to Flexus: The Science And Strategy Behind A Huge #biotech Return http://t.co/py8IV9PdnY by @alexlash $BMY $INCY $NLNK $AMGN http://www.xconomy.com/san-francisco/2015/02/26/yes-to-flexus-the-science-and-strategy-behind-a-huge-biotech-return/ http://www.xconomy.com/san-francisco/2015/02/26/yes-to-flexus-the-science-and-strategy-behind-a-huge-biotech-return/"  
[X Link](https://x.com/BentheFidler/status/570916597927415808)  2015-02-26T12:01Z [----] followers, [--] engagements


"West Coast #Biotech Roundup: Apple 23andMe Amgen Acadia & More http://t.co/tKMUYYY0rF by @alexlash $AAPL $AMGN $ACAD $GOOG $KYTH $ZGNX http://www.xconomy.com/san-francisco/2015/03/13/west-coast-biotech-roundup-apple-23andme-amgen-acadia-more/ http://www.xconomy.com/san-francisco/2015/03/13/west-coast-biotech-roundup-apple-23andme-amgen-acadia-more/"  
[X Link](https://x.com/BentheFidler/status/576392158262988800)  2015-03-13T14:39Z [----] followers, [--] engagements


"Seven Takeaways From Whats Hot in Boston #Biotech http://t.co/Giit6lFcW4 #xconbio $BIIB $VRTX http://www.xconomy.com/boston/2015/04/10/seven-takeaways-from-whats-hot-in-boston-biotech/ http://www.xconomy.com/boston/2015/04/10/seven-takeaways-from-whats-hot-in-boston-biotech/"  
[X Link](https://x.com/BentheFidler/status/586484292533923840)  2015-04-10T11:02Z [----] followers, [--] engagements


"Ex-Pfizer Exec Gutierrez-Ramos to Lead Synlogics Smart Bug Plan http://t.co/JBhKlmENQM $PFE @atlasventure #startups http://www.xconomy.com/boston/2015/05/21/ex-pfizer-exec-gutierrez-ramos-to-lead-synlogics-smart-bug-plan/ http://www.xconomy.com/boston/2015/05/21/ex-pfizer-exec-gutierrez-ramos-to-lead-synlogics-smart-bug-plan/"  
[X Link](https://x.com/BentheFidler/status/601356944943783937)  2015-05-21T12:00Z [----] followers, [--] engagements


"East Coast #Biotech Roundup: XTuit Spero Unum RNAi Feud & More http://t.co/YTdD6wpPfn $REGN $AGIO $SAGE $ALNY $DRNA $BLUE $CELG $FOLD http://www.xconomy.com/boston/2015/06/12/east-coast-biotech-roundup-xtuit-spero-unum-rnai-feud-more/ http://www.xconomy.com/boston/2015/06/12/east-coast-biotech-roundup-xtuit-spero-unum-rnai-feud-more/"  
[X Link](https://x.com/BentheFidler/status/609361274313539584)  2015-06-12T14:07Z [----] followers, [--] engagements


"West Coast Biotech Roundup: Avalanche CytomX BioMarin Dubs & More http://t.co/kIBwcaNm08 by @alexlash $AAVL $AMGN $BMRN $TKMR $KYTH $JUNO http://www.xconomy.com/san-francisco/2015/06/19/west-coast-biotech-roundup-avalanche-cytomx-biomarin-dubs-more/ http://www.xconomy.com/san-francisco/2015/06/19/west-coast-biotech-roundup-avalanche-cytomx-biomarin-dubs-more/"  
[X Link](https://x.com/BentheFidler/status/611997096787509248)  2015-06-19T20:40Z [----] followers, [--] engagements


"Keeping Score Clinical Watchdogs Push Drugmakers For More Open Data new column from @alexlash $GSK $GILD $PFE http://www.xconomy.com/national/2015/11/17/keeping-score-clinical-watchdogs-push-drugmakers-for-more-open-data/ http://www.xconomy.com/national/2015/11/17/keeping-score-clinical-watchdogs-push-drugmakers-for-more-open-data/"  
[X Link](https://x.com/BentheFidler/status/666581191168921600)  2015-11-17T11:38Z [----] followers, [--] engagements


"ICYMI earlier: Bio Pioneer Tom Maniatis Looks to Spark NY Scene Again w/ Kallyope @Lux_capital http://www.xconomy.com/new-york/2015/12/10/tom-maniatis-gives-ny-biotech-another-jolt-as-kallyope-gets-44m/ http://www.xconomy.com/new-york/2015/12/10/tom-maniatis-gives-ny-biotech-another-jolt-as-kallyope-gets-44m/"  
[X Link](https://x.com/BentheFidler/status/675066684970041344)  2015-12-10T21:36Z [----] followers, [--] engagements


"CRISPR Hits Wall Street as Editas Bags $94M in IPO $EDIT $ALNY $ONCE #CRISPR @EditasMed http://www.xconomy.com/boston/2016/02/02/crispr-hits-wall-street-as-editas-bags-94m-in-ipo/ http://www.xconomy.com/boston/2016/02/02/crispr-hits-wall-street-as-editas-bags-94m-in-ipo/"  
[X Link](https://x.com/BentheFidler/status/694676295020584961)  2016-02-03T00:18Z [----] followers, [--] engagements


"With BioMarin Data Gene Therapy Finally Shows Impact on #Hemophilia A $BMRN $DMTX $QURE $ONCE http://www.xconomy.com/san-francisco/2016/04/20/with-biomarin-data-gene-therapy-finally-shows-impact-on-hemophilia-a/ http://www.xconomy.com/san-francisco/2016/04/20/with-biomarin-data-gene-therapy-finally-shows-impact-on-hemophilia-a/"  
[X Link](https://x.com/BentheFidler/status/722938439054692352)  2016-04-21T00:02Z [----] followers, [--] engagements


"Led by Ex-Suros Execs Nico is Out To Change Brain Surgery #startups $HOLX $BSX http://www.xconomy.com/indiana/2016/04/27/led-by-ex-suros-execs-nico-is-out-to-change-brain-surgery/ http://www.xconomy.com/indiana/2016/04/27/led-by-ex-suros-execs-nico-is-out-to-change-brain-surgery/"  
[X Link](https://x.com/BentheFidler/status/725278235098025984)  2016-04-27T10:59Z [----] followers, [--] engagements


"Ariad Sells Off Europe Hub Drug Rights in $140M Incyte Deal $ARIA $INCY http://www.xconomy.com/boston/2016/05/09/ariad-sells-off-europe-hub-drug-rights-in-140m-incyte-deal/ http://www.xconomy.com/boston/2016/05/09/ariad-sells-off-europe-hub-drug-rights-in-140m-incyte-deal/"  
[X Link](https://x.com/BentheFidler/status/729643872968658945)  2016-05-09T12:07Z [----] followers, [--] engagements


"Pfizer Moving on From Allergan Pays $5.2B For Anacor Pharma $PFE $ANAC $CELG http://www.xconomy.com/san-francisco/2016/05/16/pfizer-moving-on-from-allergan-pays-5-2b-for-anacor-pharma/ http://www.xconomy.com/san-francisco/2016/05/16/pfizer-moving-on-from-allergan-pays-5-2b-for-anacor-pharma/"  
[X Link](https://x.com/BentheFidler/status/732186960635236352)  2016-05-16T12:32Z [----] followers, [--] engagements


"Spero Rolls up More Antibiotics With Vertex Deal $VRTX #startups http://www.xconomy.com/boston/2016/05/25/spero-rolls-up-more-antibiotics-with-vertex-deal/ http://www.xconomy.com/boston/2016/05/25/spero-rolls-up-more-antibiotics-with-vertex-deal/"  
[X Link](https://x.com/BentheFidler/status/735461434751111168)  2016-05-25T13:24Z [----] followers, [--] engagements


"Harvards Springer Gets $51.5M From Pharmas Others For Latest Startup $PFE $ABBV $GSK http://www.xconomy.com/boston/2016/06/30/harvards-springer-gets-51-5m-from-pharmas-others-for-latest-startup/ http://www.xconomy.com/boston/2016/06/30/harvards-springer-gets-51-5m-from-pharmas-others-for-latest-startup/"  
[X Link](https://x.com/BentheFidler/status/748478831082803200)  2016-06-30T11:30Z [----] followers, [--] engagements


"With $40M Bid Pfizer Set to Buy And Close Bankrupt Bind Tx $BIND $PFE http://www.xconomy.com/boston/2016/07/27/with-40m-bid-pfizer-set-to-buy-and-close-bankrupt-bind-tx/ http://www.xconomy.com/boston/2016/07/27/with-40m-bid-pfizer-set-to-buy-and-close-bankrupt-bind-tx/"  
[X Link](https://x.com/BentheFidler/status/758315935421923328)  2016-07-27T14:59Z [----] followers, [--] engagements


"At Big #Hemophilia Meeting More Data and Promise For Gene Therapy $BMRN $ONCE $QURE $SHPG $SGMO http://www.xconomy.com/national/2016/07/28/at-big-hemophilia-meeting-more-data-and-promise-for-gene-therapy/ http://www.xconomy.com/national/2016/07/28/at-big-hemophilia-meeting-more-data-and-promise-for-gene-therapy/"  
[X Link](https://x.com/BentheFidler/status/758708903366590465)  2016-07-28T17:01Z [----] followers, [--] engagements


"Seeking to Join Editas Intellia #CRISPR Tx Makes Long Awaited #IPO Push $EDIT $NTLA $VRTX http://www.xconomy.com/boston/2016/09/12/seeking-to-join-editas-intellia-crispr-tx-makes-long-awaited-ipo-push/ http://www.xconomy.com/boston/2016/09/12/seeking-to-join-editas-intellia-crispr-tx-makes-long-awaited-ipo-push/"  
[X Link](https://x.com/BentheFidler/status/775311234832949248)  2016-09-12T12:32Z [----] followers, [--] engagements


"After New Data FDA Bucks Advisory Panel Approves #Duchenne Drug $SRPT $BMRN $PTCT http://www.xconomy.com/boston/2016/09/19/after-new-data-fda-bucks-advisory-panel-approves-duchenne-drug/ http://www.xconomy.com/boston/2016/09/19/after-new-data-fda-bucks-advisory-panel-approves-duchenne-drug/"  
[X Link](https://x.com/BentheFidler/status/777885153322471424)  2016-09-19T15:00Z [----] followers, [--] engagements


"#Biotech Roundup: Theranos Cuts Alnylam Stops Nobel Eats Its Own & More by @alexlash $ALNY $SRPT $REGN $LLY http://www.xconomy.com/national/2016/10/07/bio-roundup-theranos-cuts-alnylam-stops-nobel-eats-its-own-more/ http://www.xconomy.com/national/2016/10/07/bio-roundup-theranos-cuts-alnylam-stops-nobel-eats-its-own-more/"  
[X Link](https://x.com/BentheFidler/status/784346567813783553)  2016-10-07T10:56Z [----] followers, [--] engagements


"After Hubris and Its HCV Collapse Can Vertex Avoid Same Mistakes $VRTX $GILD http://www.xconomy.com/boston/2016/10/18/after-hubris-and-its-hcv-collapse-can-vertex-avoid-same-mistakes/ http://www.xconomy.com/boston/2016/10/18/after-hubris-and-its-hcv-collapse-can-vertex-avoid-same-mistakes/"  
[X Link](https://x.com/BentheFidler/status/788332863762694144)  2016-10-18T10:56Z [----] followers, [--] engagements


"#Biotech Roundup: Trumps Rx Silence PCSK9 News Amgens Migraines & More $REGN $AMGN $GILD $MDCO http://www.xconomy.com/national/2016/11/18/bio-roundup-trumps-rx-silence-pcsk9-news-amgens-migraines-more/ http://www.xconomy.com/national/2016/11/18/bio-roundup-trumps-rx-silence-pcsk9-news-amgens-migraines-more/"  
[X Link](https://x.com/BentheFidler/status/799581713714315264)  2016-11-18T11:55Z [----] followers, [--] engagements


"14 For 17: Key Clinical Data to Watch For Next Year (Part 1) $REGN $BLUE $AZN $VRTX $AXON http://www.xconomy.com/national/2016/12/21/14-for-17-key-clinical-data-to-watch-for-next-year-part-1/ http://www.xconomy.com/national/2016/12/21/14-for-17-key-clinical-data-to-watch-for-next-year-part-1/"  
[X Link](https://x.com/BentheFidler/status/811652378768375808)  2016-12-21T19:19Z [----] followers, [--] engagements


"14 for 17: Key Clinical Data To Watch For Next Year (Part 2) $CLLS $ALNY $SAGE $CELG $ALDR http://www.xconomy.com/national/2016/12/22/14-for-17-key-clinical-data-to-watch-for-next-year-part-2/ http://www.xconomy.com/national/2016/12/22/14-for-17-key-clinical-data-to-watch-for-next-year-part-2/"  
[X Link](https://x.com/BentheFidler/status/811905985430388736)  2016-12-22T12:07Z [----] followers, [--] engagements


"Biotech Roundup: JPM Deals Gender Diversity PCSK9 Battle & More #JPM17 $REGN $SRPT $ARIA $VRTX http://www.xconomy.com/national/2017/01/13/biotech-roundup-jpm-deals-gender-diversity-pcsk9-battle-more/ http://www.xconomy.com/national/2017/01/13/biotech-roundup-jpm-deals-gender-diversity-pcsk9-battle-more/"  
[X Link](https://x.com/BentheFidler/status/819909038855094273)  2017-01-13T14:08Z [----] followers, [--] engagements


"Investors Sour on Data Debut For Dimensions Hemophilia Gene Therapy $DMTX $ONCE $QURE $BMRN http://www.xconomy.com/boston/2017/01/31/investors-sour-on-data-debut-for-dimensions-hemophilia-gene-therapy/ http://www.xconomy.com/boston/2017/01/31/investors-sour-on-data-debut-for-dimensions-hemophilia-gene-therapy/"  
[X Link](https://x.com/BentheFidler/status/826480313887027202)  2017-01-31T17:20Z [----] followers, [--] engagements


"At Arrakis Gilman Teams With Biogen Vets to Target RNA With Pills #startups $BIIB $CELG $PFE http://www.xconomy.com/boston/2017/02/27/at-arrakis-gilman-teams-with-biogen-vets-to-target-rna-with-pills/ http://www.xconomy.com/boston/2017/02/27/at-arrakis-gilman-teams-with-biogen-vets-to-target-rna-with-pills/"  
[X Link](https://x.com/BentheFidler/status/836184239645282304)  2017-02-27T12:00Z [----] followers, [--] engagements


"#Biotech Roundup: Spinraza Woes Science March Baseline Launch & More $BIIB $TSRO $NVS $RARE http://www.xconomy.com/national/2017/04/21/bio-roundup-spinraza-woes-science-march-baseline-launch-more/ http://www.xconomy.com/national/2017/04/21/bio-roundup-spinraza-woes-science-march-baseline-launch-more/"  
[X Link](https://x.com/BentheFidler/status/855382062139928576)  2017-04-21T11:25Z [----] followers, [--] engagements


"#Biotech Roundup: Big Apple Mo Checkpoint Yes and No CAR-T Death & More by @alexlash $KITE $MRK $PTCT $PFE http://www.xconomy.com/national/2017/05/12/bio-roundup-big-apple-mo-checkpoint-yes-and-no-car-t-death-more/ http://www.xconomy.com/national/2017/05/12/bio-roundup-big-apple-mo-checkpoint-yes-and-no-car-t-death-more/"  
[X Link](https://x.com/BentheFidler/status/862986673273098240)  2017-05-12T11:03Z [----] followers, [--] engagements


"Radius Shares Jump as Amgens Bone Drug Suffers a Setback in Phase [--] $AMGN $RDUS $LLY http://www.xconomy.com/san-francisco/2017/05/22/radius-shares-jump-as-amgens-bone-drug-suffers-a-setback-in-phase-3/ http://www.xconomy.com/san-francisco/2017/05/22/radius-shares-jump-as-amgens-bone-drug-suffers-a-setback-in-phase-3/"  
[X Link](https://x.com/BentheFidler/status/866623606515793920)  2017-05-22T11:55Z [----] followers, [--] engagements


"Precision Steps: Can Loxo Drug Help Broaden Use of Cancer DNA Tests $LOXO $RXDX $FMI $TMO #ASCO17 http://www.xconomy.com/national/2017/06/03/precision-steps-can-loxo-drug-help-broaden-use-of-cancer-dna-tests/ http://www.xconomy.com/national/2017/06/03/precision-steps-can-loxo-drug-help-broaden-use-of-cancer-dna-tests/"  
[X Link](https://x.com/BentheFidler/status/870966011914268672)  2017-06-03T11:30Z [----] followers, [--] engagements


"#Biotech Roundup: Frazier v. Trump Data Dumps New York Steps & More $MRK $BMY $AZN $REGN $NVO http://www.xconomy.com/national/2017/08/18/bio-roundup-frazier-v-trump-data-dumps-new-york-steps-more/ http://www.xconomy.com/national/2017/08/18/bio-roundup-frazier-v-trump-data-dumps-new-york-steps-more/"  
[X Link](https://x.com/BentheFidler/status/898517234439475200)  2017-08-18T12:09Z [----] followers, [--] engagements


"Alnylam Data Puts A Nobel Discovery One Step Closer To Approved Drug $ALNY $IONS $SNY #RNAi http://www.xconomy.com/boston/2017/09/20/alnylam-data-puts-a-nobel-discovery-one-step-closer-to-approved-drug/ http://www.xconomy.com/boston/2017/09/20/alnylam-data-puts-a-nobel-discovery-one-step-closer-to-approved-drug/"  
[X Link](https://x.com/BentheFidler/status/910464347427807233)  2017-09-20T11:23Z [----] followers, [--] engagements


"#Biotech Roundup: RNAis Big Day CAR-T For Kids Drugs From Fungi & More $ALNY $NVS $ESRX $ICPT http://www.xconomy.com/national/2017/09/22/bio-roundup-rnais-big-day-car-t-for-kids-drugs-from-fungi-more/ http://www.xconomy.com/national/2017/09/22/bio-roundup-rnais-big-day-car-t-for-kids-drugs-from-fungi-more/"  
[X Link](https://x.com/BentheFidler/status/911183008136343552)  2017-09-22T10:58Z [----] followers, [--] engagements


"#Biotech Roundup: Opioid News #ASH17 Preview Boston Bio IPOs & More $JUNO $NVS $BLUE $AVXS $ALNY http://www.xconomy.com/national/2017/11/03/biotech-roundup-opioid-news-ash-preview-boston-bio-ipos-more/ http://www.xconomy.com/national/2017/11/03/biotech-roundup-opioid-news-ash-preview-boston-bio-ipos-more/"  
[X Link](https://x.com/BentheFidler/status/926405191972343808)  2017-11-03T11:06Z [----] followers, [--] engagements


"15 For 18: Key Clinical Data to Watch For Next Year (Part 1) $BMY $AVXS $FGEN $XLRN $ESPR https://www.xconomy.com/national/2017/12/04/15-for-18-key-clinical-data-to-watch-for-next-year-part-1/ https://www.xconomy.com/national/2017/12/04/15-for-18-key-clinical-data-to-watch-for-next-year-part-1/"  
[X Link](https://x.com/BentheFidler/status/937652987941543937)  2017-12-04T12:01Z [----] followers, [--] engagements


"Gene Therapy Advances But #Hemophilia is no Easy Target $BMRN $ONCE $QURE #GeneTherapy https://www.xconomy.com/national/2017/12/13/gene-therapy-advances-but-hemophilia-is-no-easy-target/ https://www.xconomy.com/national/2017/12/13/gene-therapy-advances-but-hemophilia-is-no-easy-target/"  
[X Link](https://x.com/BentheFidler/status/940915672728723458)  2017-12-13T12:05Z [----] followers, [--] engagements


"Notes From the #JPM18 Vortex: Gene Therapys Reckoning and Lonely Cabs $ONCE $BLUE $ALNY https://www.xconomy.com/national/2018/01/11/notes-from-the-jpm-18-vortex-gene-therapys-reckoning-and-lonely-cabs/ https://www.xconomy.com/national/2018/01/11/notes-from-the-jpm-18-vortex-gene-therapys-reckoning-and-lonely-cabs/"  
[X Link](https://x.com/BentheFidler/status/951446026388492288)  2018-01-11T13:29Z [----] followers, [--] engagements


"#Biotech Roundup: Lung Cancer Questions Migraine Races HIV Battle & More $BMY $TEVA $GILD $JNJ https://www.xconomy.com/national/2018/02/09/bio-roundup-lung-cancer-questions-migraine-races-hiv-battle-more/ https://www.xconomy.com/national/2018/02/09/bio-roundup-lung-cancer-questions-migraine-races-hiv-battle-more/"  
[X Link](https://x.com/BentheFidler/status/961933535320924160)  2018-02-09T12:03Z [----] followers, [--] engagements


"ICYMI: Execs Talk Hurdles As Immunotherapy Combos CAR-T Launches Progress #BIOCEO18 $BMY $MRK $GILD $NVS $MBIO https://www.xconomy.com/new-york/2018/02/12/execs-talk-hurdles-as-immunotherapy-combos-car-t-launches-progress/ https://www.xconomy.com/new-york/2018/02/12/execs-talk-hurdles-as-immunotherapy-combos-car-t-launches-progress/"  
[X Link](https://x.com/BentheFidler/status/963382923973013504)  2018-02-13T12:02Z [----] followers, [--] engagements


"With $69M Deal AbbVie Turns to Voyager for an #Alzheimers Gene Therapy $VYGR $ABBV https://www.xconomy.com/boston/2018/02/20/with-69m-deal-abbvie-turns-to-voyager-for-an-alzheimers-gene-therapy/ https://www.xconomy.com/boston/2018/02/20/with-69m-deal-abbvie-turns-to-voyager-for-an-alzheimers-gene-therapy/"  
[X Link](https://x.com/BentheFidler/status/965943228720697344)  2018-02-20T13:36Z [----] followers, [--] engagements


"#Biotech Roundup: DIY Biohacking PCSK9 Data Solid Setback & More $REGN $SLDB $IONS $BIIB $GILD https://www.xconomy.com/national/2018/03/16/bio-roundup-diy-biohacking-pcsk9-data-solid-bio-stopped-more/ https://www.xconomy.com/national/2018/03/16/bio-roundup-diy-biohacking-pcsk9-data-solid-bio-stopped-more/"  
[X Link](https://x.com/BentheFidler/status/974601623556251648)  2018-03-16T11:01Z [----] followers, [--] engagements


"AbbVie Shares Plummet as $5.8B Bet on Stemcentrx Takes a Hit $ABBV https://www.xconomy.com/national/2018/03/22/abbvie-shares-plummet-as-5-8b-bet-on-stemcentrx-takes-a-hit/ https://www.xconomy.com/national/2018/03/22/abbvie-shares-plummet-as-5-8b-bet-on-stemcentrx-takes-a-hit/"  
[X Link](https://x.com/BentheFidler/status/976832944391229440)  2018-03-22T14:48Z [----] followers, [--] engagements


"Racing Allergan Biohaven Touts #Migraine Drug Data But Shares Sink $BHVN $AGN $BMY $MRK $LLY https://www.xconomy.com/new-york/2018/03/26/racing-allergan-biohaven-touts-migraine-drug-data-but-shares-sink/ https://www.xconomy.com/new-york/2018/03/26/racing-allergan-biohaven-touts-migraine-drug-data-but-shares-sink/"  
[X Link](https://x.com/BentheFidler/status/978244356627935233)  2018-03-26T12:16Z [----] followers, [--] engagements


"Roche-Exelixis Study Fails as Mixed Year Continues For Cancer Drug Combos $EXEL $ARRY $MRK https://www.xconomy.com/san-francisco/2018/05/10/roche-exelixis-study-fails-as-mixed-year-continues-for-cancer-drug-combos/ https://www.xconomy.com/san-francisco/2018/05/10/roche-exelixis-study-fails-as-mixed-year-continues-for-cancer-drug-combos/"  
[X Link](https://x.com/BentheFidler/status/994555847895388161)  2018-05-10T12:32Z [----] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing